Drug maker ‘will make $21bn from treating cystic fibrosis’

Vertex is accused of raking in vast profits while making Orkambi unaffordable to NHS A US company, which is refusing to drop its price for the life-changing cystic fibrosis drug Orkambi to make it affordable to NHS England, is set to make $21bn (£17bn)…

Read more

China’s child modelling industry – a photo essay

Manicured children strut down the catwalks of Beijing fashion shows as thousands of events drive the huge demand for child models. Insiders warn that modelling can leave minors vulnerable to physical abuse, 12-hour-days and unrelenting pressureA buyer …

Read more

The Guardian view on ice-cream vans: shame about the pollution | Editorial

Their tinny chimes may be an essential sound of the summer. But are they out of tune with the times?Few things could be quite so evocative as the memory of childhood greed sharpened by the jarring, tinny sound of Waltzing Matilda or Greensleeves heard …

Read more